Literature DB >> 23674386

SNCA: major genetic modifier of age at onset of Parkinson's disease.

Kathrin Brockmann1, Claudia Schulte, Ann-Kathrin Hauser, Peter Lichtner, Heiko Huber, Walter Maetzler, Daniela Berg, Thomas Gasser.   

Abstract

Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single-nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society.
Copyright © 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; SNCA; age at onset; genetics

Mesh:

Substances:

Year:  2013        PMID: 23674386     DOI: 10.1002/mds.25469

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  [Genetic risk variants in Parkinson's disease and other movement disorders].

Authors:  K Brockmann; K Lohmann
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

2.  Multimodal neuroimaging and behavioral assessment of α-synuclein polymorphism rs356219 in older adults.

Authors:  Roxana G Burciu; Rachael D Seidler; Priyank Shukla; Mike A Nalls; Andrew B Singleton; Michael S Okun; David E Vaillancourt
Journal:  Neurobiol Aging       Date:  2018-02-10       Impact factor: 4.673

Review 3.  The significance of GBA for Parkinson's disease.

Authors:  Kathrin Brockmann; Daniela Berg
Journal:  J Inherit Metab Dis       Date:  2014-06-04       Impact factor: 4.982

4.  No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.

Authors:  Victoria Berge-Seidl; Lasse Pihlstrøm; Zbigniew K Wszolek; Owen A Ross; Mathias Toft
Journal:  Neurobiol Aging       Date:  2018-09-22       Impact factor: 4.673

5.  Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

Authors:  Cornelis Blauwendraat; Karl Heilbron; Costanza L Vallerga; Sara Bandres-Ciga; Rainer von Coelln; Lasse Pihlstrøm; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Alastair J Noyce; Manuela Tan; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Joseph Jankovic; Lisa M Shulman; Suzanne Lesage; Jean-Christophe Corvol; Alexis Brice; Jacobus J van Hilten; Johan Marinus; Johanna Eerola-Rautio; Pentti Tienari; Kari Majamaa; Mathias Toft; Donald G Grosset; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicolas Wood; John Hardy; Huw R Morris; David A Hinds; Jacob Gratten; Peter M Visscher; Ziv Gan-Or; Mike A Nalls; Andrew B Singleton
Journal:  Mov Disord       Date:  2019-04-07       Impact factor: 10.338

6.  SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.

Authors:  Rubén Fernández-Santiago; Núria Martín-Flores; Francesca Antonelli; Catalina Cerquera; Verónica Moreno; Sara Bandres-Ciga; Elisabetta Manduchi; Eduard Tolosa; Andrew B Singleton; Jason H Moore; María-Josep Martí; Mario Ezquerra; Cristina Malagelada
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

7.  Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes.

Authors:  Isabel Alfradique-Dunham; Rami Al-Ouran; Rainer von Coelln; Cornelis Blauwendraat; Emily Hill; Lan Luo; Amanda Stillwell; Emily Young; Anita Kaw; Manuela Tan; Calwing Liao; Dena Hernandez; Lasse Pihlstrom; Donald Grosset; Lisa M Shulman; Zhandong Liu; Guy A Rouleau; Mike Nalls; Andrew B Singleton; Huw Morris; Joseph Jankovic; Joshua M Shulman
Journal:  Neurol Genet       Date:  2021-01-28

8.  SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.

Authors:  Yue Huang; Gang Wang; Dominic Rowe; Ying Wang; John B J Kwok; Qin Xiao; Frank Mastaglia; Jun Liu; Sheng-Di Chen; Glenda Halliday
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

Review 9.  A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.

Authors:  Camilla Christina Pedersen; Johannes Lange; Marthe Gurine Gunnarsdatter Førland; Angus D Macleod; Guido Alves; Jodi Maple-Grødem
Journal:  NPJ Parkinsons Dis       Date:  2021-07-01

Review 10.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.